PTIX Insider Trading Activity and SEC Form 4 Filings
PTIX insider trading summary
Over the past 12 months, insiders at Protagenic Therapeutics, Inc.\new (PTIX) reported 7 open-market purchases worth $31K by 1 insider and no sales on SEC Form 4. Net insider buying was $31K.
Latest PTIX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 21, 2026 | Garo H Armen | Exec. Chair & Principal Off | Buy | $13K (20,000 @ $0.65) |
| Aug 20, 2026 | Garo H Armen | Exec. Chair & Principal Off | Buy | $10K (16,634 @ $0.59) |
| Aug 19, 2026 | Garo H Armen | Exec. Chair & Principal Off | Buy | $945 (2,700 @ $0.35) |
| Aug 11, 2026 | Garo H Armen | Exec. Chair & Principal Off | Buy | $710 (2,220 @ $0.32) |
| Aug 6, 2026 | Garo H Armen | Exec. Chair & Principal Off | Buy | $151 (685 @ $0.22) |
| Aug 5, 2026 | Garo H Armen | Exec. Chair & Principal Off | Buy | $1K (5,000 @ $0.26) |
| Jul 30, 2026 | Garo H Armen | Exec. Chair & Principal Off. | Buy | $5K (26,291 @ $0.18) |
| Oct 12, 2023 | Alexander K. Arrow | Chief Financial Officer | Buy | $6K (8,000 @ $0.81) |
| May 18, 2022 | Alexander K. Arrow | Chief Financial Officer | Buy | $6K (8,000 @ $0.72) |
| May 17, 2022 | Alexander K. Arrow | Chief Financial Officer | Buy | $16K (23,000 @ $0.71) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.